|
|
|
|
LEADER |
01338nam a2200325 u 4500 |
001 |
EB001892170 |
003 |
EBX01000000000000001055317 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
200301 r ||| eng |
100 |
1 |
|
|a Mayhew, Alain
|
245 |
0 |
0 |
|a Ivabradine for adults with stable chronic heart failure
|h Elektronische Ressource
|b a review of clinical effectiveness
|c Alain Mayhew, Hannah Loshak
|
250 |
|
|
|a Version 1.0
|
260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c May 15, 2019, 2019
|
300 |
|
|
|a 1 PDF file (17 pages)
|b illustrations
|
505 |
0 |
|
|a Includes bibliographical references
|
653 |
|
|
|a Comparative Effectiveness Research
|
653 |
|
|
|a Ivabradine / therapeutic use
|
653 |
|
|
|a Canada
|
653 |
|
|
|a Chronic Disease
|
653 |
|
|
|a Cardiovascular Agents / therapeutic use
|
653 |
|
|
|a Heart Failure / drug therapy
|
700 |
1 |
|
|a Loshak, Hannah
|e [author]
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK545894
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
082 |
0 |
|
|a 700
|
082 |
0 |
|
|a 610
|